Nurofen Express 200mg Tablets
- Name:
Nurofen Express 200mg Tablets
- Company:
Reckitt Benckiser Ireland Limited
- Active Ingredients:
- Legal Category:
Supply through pharmacy only
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 02/04/20

Click on this link to Download PDF directly
Reckitt Benckiser Ireland Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 2 April 2020 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Supply through pharmacy only
Updated on 2 April 2020 PIL
Reasons for updating
- Change to section 4 - possible side effects
Updated on 15 January 2020 PIL
Reasons for updating
- Change to section 6 - manufacturer
Updated on 2 August 2018 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Supply through pharmacy only
Updated on 4 December 2017 SPC
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 9 - Date of first authorisation/renewal of the authorisation
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Renewal date updated to date of last renewal May 2016
Updated on 4 December 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through pharmacy only
Updated on 16 August 2017 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 4.4 and 4.8 updated with chicken pox warnings.
Section 10 date of revision of text updated.
Updated on 15 August 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 15 August 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
Updated on 10 October 2014 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Updated on 7 October 2014 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change to dosage and administration
Updated on 10 April 2014 PIL
Reasons for updating
- Change to warnings or special precautions for use
- Change of contraindications
Updated on 12 February 2014 SPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change due to harmonisation of SPC
Legal category: Supply through pharmacy only
Free text change information supplied by the pharmaceutical company
Section 4.4 cardiovascular & cerebrovascular effects reworded
Updated on 5 July 2011 PIL
Reasons for updating
- New PIL for new product
Updated on 22 June 2011 SPC
Reasons for updating
- New SPC for new product
Legal category: Supply through pharmacy only